Tiger Jade Capital

Tiger Jade Capital functions as a private equity fund focusing on the global healthcare sector. The firm strategically invests in critical areas including new pharmaceutical drugs, Contract Research Organizations (CROs), and advanced medical equipment. Its capital deployment targets companies poised to innovate and advance healthcare solutions, fostering progress across life sciences and medical technology.

Established in 2019, Tiger Jade Capital was founded with Jasper Jiang as a key partner. The firm originated from the insight that substantial capital is essential to drive innovation within the complex and rapidly evolving global healthcare industry. This foundation reflects a clear vision for directing investment into areas with high potential for human well-being and medical advancement.

The firm’s investments serve innovative healthcare companies, from early-stage startups to established enterprises. Tiger Jade Capital aims to aggregate "conscious capital" to fundamentally improve global well-being. Its long-term mission is to catalyze meaningful healthcare advancements, focusing on fostering sustainable growth and transformative developments within its portfolio.